Un vistazo al sistema de cannabinoides
DOI:
https://doi.org/10.29105/cienciauanl26.120-2Palabras clave:
cannabinoides, Cannabis spp., cannabinoides sintéticos, ENDOCANNABINOIDES, FITOCANNABINOIDESResumen
Existen tres tipos de cannabinoides, su estudio ha estado íntimamente relacionado entre sí, por lo que en ocasiones es difícil hablar de unos sin mencionar a los otros.
Los primeros en ser descubiertos fueron los fitocannabinoides, que vienen de la planta Cannabis spp. (Linneo, 1753).
Después de este descubrimiento se identificaron receptores que modulan la respuesta al uso del cannabis, lo cual fue apoyado con el diseño de lo que ahora conocemos como cannabinoides sintéticos.
Descargas
Citas
Aguiar, F.C.D.S.P., y Rocha, E.D. (2022). Facing the Forensic Challenge of Cannabis Regulation: A Methodology for the Differentiation between Hemp and Marijuana Samples. Brazilian Journal of Analytical Chemistry. 9(34):162-176. Doi: 10.30744/brjac.2179-3425.AR-42-2021 DOI: https://doi.org/10.30744/brjac.2179-3425.AR-42-2021
ElSohly, M.A., Radwan, M.M., Gul, W., et al. (2017). Phytochemistry of Cannabis sativa L. Prog. Chem. Org. Nat. Prod. 103:136. Doi: 10.1007/978-3-319-45541-9_1 DOI: https://doi.org/10.1007/978-3-319-45541-9_1
Freitas, H. (2022). Medical Cannabis-A Historical Perspective. Preprints, 2022040054. Doi: 10.20944/preprints202204.0054.v1 DOI: https://doi.org/10.20944/preprints202204.0054.v1
Grotenhermen, F. (2005). Cannabinoids. Current Drug Targets-CNS & Neurological Disorders. 4(5):5075- 30. Doi: 10.2174/156800705774322111 DOI: https://doi.org/10.2174/156800705774322111
Hand, A., Blake, A., Kerrigan, P., et al. (2016). History of medical Cannabis. J Pain Manage. 9:387-394.
Ho, T.C., y Tius, M.A. (2019). Synthesis of Classical/Nonclassical Hybrid Cannabinoids and Related Compounds. In Cutting-Edge Organic Synthesis and Chemical Biology of Bioactive Molecules, Chapter 11. Springer, Singapore. DOI: https://doi.org/10.1007/978-981-13-6244-6_11
Izzo, A., Borrelli, F., Capasso, R., et al. (2009). Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol. Sci. 30(10):515- 27. Doi: 10.1016/j.tips.2009.07.006 DOI: https://doi.org/10.1016/j.tips.2009.07.006
Linnaeus, C. (1793). Species Plantarum. Vol. 1. London.
Li, H.-L. (1974). An Archaeological and Historical Account of Cannabis in China. Economic Botany. 28(4):437-448. DOI: https://doi.org/10.1007/BF02862859
NIDA. (2011). Febrero 1. Cannabinoides sintéticos (K2/Spice)-DrugFacts. Disponible en: https://nida.nih.gov/es/publicaciones/drugfacts/cannabinoides-sinteticos-k2spice-en 2022, September 20
Pertwee, R.G. (2015). Endocannabinoids and their pharmacological actions. Endocannabinoids, 13- 7. Handbook of Experimental Pharmacology. Vol. 231. Springer, Cham. Doi: 10.1007/9783319-20825-1_1 DOI: https://doi.org/10.1007/978-3-319-20825-1_1
Peyravian, N., Deo, S., Daunert, S., et al. (2020). Cannabidiol as a novel therapeutic for immune modulation. ImmunoTargets and Therapy. 9:131-140. Doi: 10.2147/ITT.S263690 DOI: https://doi.org/10.2147/ITT.S263690
Rehman, M., Fahad, S., Du, G., et al. (2021). Evaluation of hemp (Cannabis sativa L.) as an industrial crop: A review. Environmental Science and Pollution Research. 28(38):528325-2843. Doi: 10.1007/s11356-021-162645 DOI: https://doi.org/10.1007/s11356-021-16264-5
Salzet, M., Breton, C., Bisogno, T., et al. (2000). Comparative biology of the endocannabinoid system: possible role in the immunea response. European Journal of Biochemistry. 267(16): 4917-4927. Doi: 10.1046/j.1432-1327.2000.01550.x DOI: https://doi.org/10.1046/j.1432-1327.2000.01550.x
Silvestro, S., Schepici, G., Bramanti, P., et al. (2020). Molecular targets of cannabidiol in experimental models of neurological disease. Molecules. 25(21):5186. DOI: https://doi.org/10.3390/molecules25215186
Singla, R.K., Guimarães, A.G., y Zengin, G. (2021). Application of plant secondary metabolites to pain neuromodulation. Frontiers in Pharmacology. 11:623399. DOI: https://doi.org/10.3389/fphar.2020.623399
Turner, S.E., Williams, C.M., Iversen, L., et al. (2017). Molecular Pharmacology of Phytocannabinoids. Progress in the Chemistry of Organic Natural Products. Vol 103. Springer, Cham. Doi: 10.1007/9783319-45541-9_3 DOI: https://doi.org/10.1007/978-3-319-45541-9_3
World Health Organization. (2018). Cannabidiol (CBD) Critical review report, expert committee on drug dependence. Expert Committee on Drug Dependence Fortieth Meeting. Disponible en: https://www.who.int/docs/default-source/controlled-substances/whocbdreportmay2018-2.pdf?sfvrsn=f78db177_2
Wood, T.B., Spivey, W.N., y Easterfield, T.H. (1896). XL.-Charas. The resin of Indian hemp. Journal of the Chemical Society, Transactions.69:5395-46. DOI: https://doi.org/10.1039/CT8966900539
Zuardi, A.W. (2006). History of Cannabis as a medicine: a review. Braz J Psiquiatria. 28(2):153-7. Doi: 10.1590/s1516-44462006000200015. DOI: https://doi.org/10.1590/S1516-44462006000200015
